Cargando…
Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin
BACKGROUND: Transitional cell carcinoma is the most common bladder cancer of dogs. Cisplatin combined with piroxicam provides superior response rates, but unacceptable rates of nephrotoxicity. Tavocept is a chemoprotectant that has mitigated cisplatin toxicity and decreased the required infusion/diu...
Autores principales: | Henry, C.J., Flesner, B.K., Bechtel, S.A., Bryan, J.N., Tate, D.J., Selting, K.A., Lattimer, J.C., Bryan, M.E., Grubb, L., Hausheer, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787204/ https://www.ncbi.nlm.nih.gov/pubmed/29080252 http://dx.doi.org/10.1111/jvim.14848 |
Ejemplares similares
-
Autologous cancer cell vaccination, adoptive T‐cell transfer, and interleukin‐2 administration results in long‐term survival for companion dogs with osteosarcoma
por: Flesner, Brian K., et al.
Publicado: (2020) -
Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia
por: Axiak‐Bechtel, Sandra M., et al.
Publicado: (2023) -
Thymidine Kinase Type 1 and C‐Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer
por: Selting, K.A., et al.
Publicado: (2016) -
Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs
por: Adin, Darcy, et al.
Publicado: (2021) -
Evaluation of Serum Thyroid‐Stimulating Hormone Concentration as a Diagnostic Test for Hyperthyroidism in Cats
por: Peterson, M.E., et al.
Publicado: (2015)